295 related articles for article (PubMed ID: 8352069)
1. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
[TBL] [Abstract][Full Text] [Related]
2. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
[TBL] [Abstract][Full Text] [Related]
4. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats.
Toolan BC; Shea M; Myers ER; Borchers RE; Seedor JG; Quartuccio H; Rodan G; Hayes WC
J Bone Miner Res; 1992 Dec; 7(12):1399-406. PubMed ID: 1481726
[TBL] [Abstract][Full Text] [Related]
5. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats.
Azuma Y; Oue Y; Kanatani H; Ohta T; Kiyoki M; Komoriya K
J Pharmacol Exp Ther; 1998 Jul; 286(1):128-35. PubMed ID: 9655851
[TBL] [Abstract][Full Text] [Related]
6. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
7. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
Huang TH; Mühlbauer RC; Tang CH; Chen HI; Chang GL; Huang YW; Lai YT; Lin HS; Yang WT; Yang RS
Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
[TBL] [Abstract][Full Text] [Related]
8. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
9. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
[TBL] [Abstract][Full Text] [Related]
10. Effect of prostaglandin and bisphosphonate on cancellous bone volume and structure in the ovariectomized rat studied by quantitative three-dimensional nuclear magnetic resonance microscopy.
Takahashi M; Wehrli FW; Wehrli SL; Hwang SN; Lundy MW; Hartke J; Borah B
J Bone Miner Res; 1999 May; 14(5):680-9. PubMed ID: 10320516
[TBL] [Abstract][Full Text] [Related]
11. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
Sugimoto M; Futaki N; Harada M; Kaku S
Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
[TBL] [Abstract][Full Text] [Related]
13. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure.
Uriu K; Morimoto I; Kai K; Okazaki Y; Okada Y; Qie YL; Okimoto N; Kaizu K; Nakamura T; Eto S
Toxicol Appl Pharmacol; 2000 May; 164(3):264-72. PubMed ID: 10799336
[TBL] [Abstract][Full Text] [Related]
15. High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
Bain SD; Jensen E; Celino DL; Bailey MC; Lantry MM; Edwards MW
J Bone Miner Res; 1993 Feb; 8(2):219-30. PubMed ID: 8442440
[TBL] [Abstract][Full Text] [Related]
16. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
[TBL] [Abstract][Full Text] [Related]
17. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
18. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats.
Seedor JG; Quartuccio HA; Thompson DD
J Bone Miner Res; 1991 Apr; 6(4):339-46. PubMed ID: 1858520
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
20. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
